SXTC - China SXT Pharmaceuticals climbs on heavy volume

After back-to-back sessions of losses, the shares of China SXT Pharmaceuticals (NASDAQ:SXTC) have added more than 44% in the pre-market Tuesday on surging volume. China SXT (SXTC) is focused on research, production, and sales of traditional Chinese medicine piece tablets in China. The company has lost more than two-thirds of its value in the year so far, as shown in this graph. However, currently, over 13 million China SXT (SXTC) shares have changed hands, more than double the 65-day average volume of ~6.2 million. The sudden interest in the company comes at a time other pharmaceutical companies with roots in China have recorded modest moves in the pre-market.  Several days ago, the group made strong gains after a slump driven by U.S. regulatory concerns.

For further details see:

China SXT Pharmaceuticals climbs on heavy volume